CD8A and cancer: Furthermore, the CXCL1/CXCR2 axis can induce PMN-myeloid-derived suppressor cells (MDSCs) accumulation in the TME and induce CD8+ T cell exhaustion, which may offer a potential therapeutic strategy for cancer therapy [40].